Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patient…
Biotechnology
US, Research Triangle Park [HQ]
Resulting Ratios
15 Records · Starting from 2009
Loading...